Samuel Rae, Author at Born2Invest

Samuel Rae

Samuel is a currency trader, equities analyst, author and contributor to a number of the leading financial market publications including Futures Magazine, Master Investor, FX Trader Magazine and Spreadbet Magazine. His book, Diary of a Currency Trader, was published in 2013 by Harriman House and has since become a best seller in the forex and currency trading space. Born and educated in the UK, he currently lives in Barcelona, Spain, with his two dogs, managing a personal portfolio of mid to high-risk US equities. He specializes in small to mid-cap biotechnology, energies and mining stocks as well as bitcoin and cryptocurrencies.

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

Samuel Rae

Stories By Samuel Rae

A closer look at US Gold Corp’s Copper King project

CMO resignation highlights a key biotech catalyst for Acceleron Pharma

Here’s a look at what the latest Spark Therapeutics data means for the company

Here’s why now might be a good time to look at Oramed Pharmaceuticals